A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of dupilumab in children 6 to <12 years of age with uncontrolled persistent asthma STUDY NUMBER: EFC14153
Clinical Trial Grant
Administered By
Pediatrics, Pulmonary and Sleep Medicine
Awarded By
Sanofi US
Start Date
October 25, 2017
End Date
September 30, 2019
Administered By
Pediatrics, Pulmonary and Sleep Medicine
Awarded By
Sanofi US
Start Date
October 25, 2017
End Date
September 30, 2019